In addition, future studies investigating whether the metabolic state (e.g., plasma glucose or insulin levels, etc.)influences LEP promoter methylation in blood cells of patients with ICUS, CCUS, or MDS could potentially reveal new mechanistic insight of the methylation changes. This evidence concerns the gene LEP and myelodysplastic syndrome.